Edition:
United States

Pfizer Ltd (PFIZ.NS)

PFIZ.NS on National Stock Exchange of India

2,865.00INR
17 Oct 2018
Change (% chg)

Rs-30.80 (-1.06%)
Prev Close
Rs2,895.80
Open
Rs2,920.00
Day's High
Rs2,934.00
Day's Low
Rs2,846.20
Volume
17,571
Avg. Vol
63,640
52-wk High
Rs3,847.70
52-wk Low
Rs1,708.10

Latest Key Developments (Source: Significant Developments)

Pfizer Ltd Says Pfizer Inc Has Not Yet Made Decision w.r.t Strategic Alternatives For Global Consumer Healthcare Business​
Thursday, 1 Mar 2018 02:17am EST 

March 1 (Reuters) - Pfizer Ltd ::‍PFIZER INC. TOLD CO'S BOARD THAT NO DECISION HAS YET BEEN MADE WITH RESPECT TO ANY STRATEGIC ALTERNATIVES FOR GLOBAL CONSUMER HEALTHCARE BUSINESS​.PFIZER INC IDENTIFIED PRODUCTS OUTSIDE CONSUMER HEALTHCARE BUSINESS IN INDIA TO BE INCLUDED STRATEGIC ALTERNATIVES REVIEW FOR BUSINESS.  Full Article

Pfizer Says Ravi Prakash Bhagavathula Resigned As CFO
Monday, 19 Feb 2018 01:58am EST 

Feb 19 (Reuters) - Pfizer Ltd ::SAYS RAVI PRAKASH BHAGAVATHULA RESIGNED AS CFO.  Full Article

FDA Approves SGLT2 Inhibitor Steglatro And Fixed-Dose Combination Steglujan For Adults With Type 2 Diabetes
Friday, 22 Dec 2017 07:00am EST 

Dec 22 (Reuters) - Merck & Co Inc ::FDA APPROVES SGLT2 INHIBITOR STEGLATRO™ (ERTUGLIFLOZIN) AND FIXED-DOSE COMBINATION STEGLUJAN™ (ERTUGLIFLOZIN AND SITAGLIPTIN) FOR ADULTS WITH TYPE 2 DIABETES.MERCK & CO INC - FDA APPROVED STEGLATRO TABLETS, AN ORAL SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITOR, AND FIXED-DOSE COMBINATION STEGLUJAN TABLETS.MERCK & CO INC - IN ADDITION TO STEGLATRO & STEGLUJAN, FDA ALSO APPROVED FIXED-DOSE COMBINATION SEGLUROMET.  Full Article

Pfizer Sept-qtr profit down about 12 pct
Friday, 10 Nov 2017 03:34am EST 

Nov 10 (Reuters) - Pfizer Ltd ::Sept quarter net profit 1.11 billion rupees versus profit of 1.26 billion rupees last year.Sept quarter revenue from operations 5.71 billion rupees versus 5.58 billion rupees last year.  Full Article

India's Pfizer Ltd signs deal to buy Neksium brand from AstraZeneca AB, Sweden
Wednesday, 31 May 2017 06:38am EDT 

May 31 (Reuters) - Pfizer Ltd :Says entered into an acquisition agreement with AstraZeneca AB, Sweden.Says under agreement, brand 'Neksium' is being acquired by company in India for a consideration of INR 750 million.  Full Article

Pfizer Ltd says news on USFDA observations for Hospira Vizag unit does not relate to Pfizer, India
Friday, 24 Mar 2017 07:42am EDT 

Pfizer Ltd : Clarifies on news item "Pfizer's Hospira Vizag unit receives 11 observation from US FDA" . Says news does not relate to Pfizer Ltd, India .News appears to be related to export oriented manufacturing facility of Hospira Healthcare India, an unlisted Indian unit of Pfizer Inc, USA.  Full Article

Pfizer Ltd Dec-qtr profit up about 4 pct
Monday, 30 Jan 2017 05:40am EST 

Pfizer Ltd : Dec quarter net profit 623.7 million rupees . Dec quarter total income from operations 5.10 billion rupees .net profit in Dec quarter last year was 597.6 million rupees as per ind-as; total income from operations was 5.26 billion rupees.  Full Article

Pfizer enters into delegation of authority with Astrazeneca Pharma India
Wednesday, 18 Jan 2017 07:49am EST 

Pfizer Ltd : Pfizer Ltd says entered into delegation of authority with Astrazeneca Pharma India . Pfizer Ltd says Meronem IV injection, currently marketed in India by Astrazeneca, is expected to be transitioned to co .Pfizer Ltd - co granted authority for pricing and reimbursement talks, promotional, marketing, tendering and bidding for injectable antibiotic products.  Full Article

Pfizer Ltd Sept-qtr profit up about 52 pct
Friday, 4 Nov 2016 07:34am EDT 

Pfizer Ltd : Sept quarter net profit 1.26 billion rupees . Sept quarter total income from operations 5.58 billion rupees .Net profit in sept quarter last year was 828.4 million rupees as per Ind-AS; total income from operations was 5.31 billion rupees.  Full Article

BRIEF-India's Pfizer March Qtr Profit Rises

* MARCH QUARTER NET PROFIT 1.05 BILLION RUPEES VERSUS PROFIT OF 680.4 MILLION RUPEES YEAR AGO